Cart
sales@molnova.com
TRPV4 agonist-1 free base
CAS No. 2314467-59-7
TRPV4 agonist-1 free base( OUN67600 )
Catalog No. M24056 CAS No. 2314467-59-7
TRPV4 agonist-1 free base?is an agonist of transient receptor potential vanilloid 4 (TRPV4;EC50 of 60 nM, in the hTRPV4 Ca2+ assay).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 106 | In Stock |
|
| 10MG | 178 | In Stock |
|
| 25MG | 332 | In Stock |
|
| 50MG | 494 | In Stock |
|
| 100MG | 709 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTRPV4 agonist-1 free base
-
NoteResearch use only, not for human use.
-
Brief DescriptionTRPV4 agonist-1 free base?is an agonist of transient receptor potential vanilloid 4 (TRPV4;EC50 of 60 nM, in the hTRPV4 Ca2+ assay).
-
DescriptionTRPV4 agonist-1 free base?is an agonist of transient receptor potential vanilloid 4 (TRPV4;EC50 of 60 nM, in the hTRPV4 Ca2+ assay).
-
In VitroTRPV4 agonist-1 (Compound 36) exhibits significantly increased potency (ECmax: 20 nM in the SOX9 reporter assay). TRPV4 agonist-1 is inactive against TRPV1 channels.
-
In Vivo——
-
SynonymsOUN67600
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPV4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2314467-59-7
-
Formula Weight448.46
-
Molecular FormulaC25H22F2N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:83.33 mg/mL?(185.81 mM;?Need ultrasonic)
-
SMILESCN1CCN(CC1)C2=NC3=C(C=CC=C3F)C(=O)N2C4=CC=C(C=C4)OC5=CC=C(C=C5)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Atobe M, et al. Discovery of Novel Transient Receptor Potential Vanilloid 4 (TRPV4) Agonists as Regulators of Chondrogenic Differentiation: Identification of Quinazolin-4(3 H)-ones and in Vivo Studies on a Surgically Induced Rat Model of Osteoarthritis. J Med Chem. 2019 Jan 28.
molnova catalog
related products
